Ovarian cancer with peritoneal carcinomatosis is when ovarian cancer spreads to the tissue lining your abdomen and abdominal organs. It’s a common site of spread for ovarian cancer.
After uterine cancer, ovarian cancer is the
Ovarian cancer with peritoneal carcinomatosis is associated with advanced ovarian cancer. Treatment usually involves surgery and chemotherapy.
This article reviews this type of ovarian cancer in more detail, including its symptoms, treatment, and outlook.
Ovarian cancer with peritoneal carcinomatosis is when ovarian cancer has spread to the peritoneum. The
According to the
Researchers estimate that spread to the peritoneum is found in
Peritoneal carcinomatosis happens when cancer cells come off of the main tumor on the ovary. These cells then travel through the fluid in the abdomen and can eventually settle and begin to grow on the peritoneum.
About
Plus, people with peritoneal carcinomatosis can also have other symptoms of advanced ovarian cancer, such as:
- pain or pressure in the abdomen or pelvis
- feeling full quickly after eating
- urgent or frequent urination
- constipation
- stomach upset or nausea
- reduced appetite
- unintentional weight loss
- back pain
- periods that are heavier or more irregular
- fatigue
The typical treatment for people with advanced ovarian cancer is a combination of surgery and chemotherapy.
The type of surgery that doctors consider is called cytoreductive surgery (CRS). Surgeons perform CRS to remove as much of the cancer as possible.
The goal of CRS is to achieve complete cytoreduction,
Depending on the extent of your cancer, CRS can involve the removal of:
- both ovaries and fallopian tubes
- the uterus
- the omentum
- the gallbladder
- the spleen
- nearby lymph nodes
- parts of the:
- pancreas
- liver
Doctors typically recommend chemotherapy after surgery. This
Another type of treatment that doctors may give after surgery is called hyperthermic intraperitoneal chemotherapy (HIPEC). In HIPEC, surgeons pump heated chemo drugs directly into your abdominal cavity.
Ovarian cancer with peritoneal carcinomatosis is associated with advanced ovarian cancer and, as such, has a
A 2020 review notes that a big factor for outlook is whether or not there’s complete cytoreduction. It cites an older study that found that complete cytoreduction is achieved in about one-third of situations.
Other factors that can affect the outlook of people who have ovarian cancer with peritoneal carcinomatosis include:
- the specific type of ovarian cancer they have
- the extent of the cancer and how aggressive it is
- which tissues, in addition to the peritoneum, are affected
- their age and overall health
How likely is recurrence from ovarian cancer with peritoneal carcinomatosis?
According to a 2022 review, most people with advanced ovarian cancer reach remission after treatment with CRS and chemo. However, the cancer may return in about 70% to 80% of people. The peritoneum is a common site of recurrence.
Ovarian cancer with peritoneal carcinomatosis is when ovarian cancer spreads into the peritoneum. The peritoneum is the tissue lining your abdomen and abdominal organs. It’s associated with advanced ovarian cancer.
The treatment for ovarian cancer with peritoneal carcinomatosis is typically surgery and chemo. The outlook can largely depend on how effectively the cancer was removed.
The symptoms of ovarian cancer are nonspecific, making it difficult to diagnose before it has spread. It’s important to see your doctor for new or persistent symptoms like bloating, pain, and feeling full shortly after eating.